MAPT and Alzheimer disease: Misfolding and aggregation of tau are closely associated with the onset and progression of AD and other related neurodegenerative disorders, such as progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and frontotemporal dementia (FTD), collectively referred to as tauopathies [41].